How fast does SPIROCLEN start working?

SPIROCLEN (Clenbuterol 40 mcg) typically begins working within 30–60 minutes, enhancing airflow and thermogenesis. Users may notice improved breathing and energy early, with fat-burning effects appearing in 1–2 weeks when combined with diet and exercise.

Can SPIROCLEN help with muscle definition during cutting cycles?

Yes, SPIROCLEN is used during cutting cycles to support fat loss while preserving lean muscle. Its thermogenic effect helps improve muscle definition and overall physique, with best results achieved alongside resistance training and a calorie-controlled diet.

Is SPIROCLEN suitable for beginners?

SPIROCLEN should be used cautiously by beginners due to its stimulant effect. New users should start with the lowest effective dose, monitor their body's response, and follow medical guidance to avoid overstimulation or elevated heart rate.

Can I work out after taking SPIROCLEN?

Many athletes take SPIROCLEN before workouts to enhance endurance, breathing, and training intensity. Users should avoid overtraining, monitor heart rate, and stay hydrated during exercise.

Will I lose weight without exercising while using SPIROCLEN?

SPIROCLEN increases metabolism and may support fat burning even at rest, but results are better with proper training and nutrition. Without exercise, weight-loss effects are moderate, and overall fitness improvements are limited.

SPIROCLEN

Name: SPIROCLEN Clenbuterol Hydrochloride Tablet
Brand: NovaTech Sciences
SKU: SPIROCLEN-CLENBUTEROL-HCL
Rating: 5 (5 reviews)

SPIROCLEN Tablet by NovaTech Sciences contains Clenbuterol (CAS 21898‑19‑1). Trusted manufacturer, supplier, and exporter of pharmaceutical‑grade performance support for fat loss, endurance, and metabolic boost.

CAS Number: 21898-19-1

SPIROCLEN (Clenbuterol 40 mcg) is indicated for bronchodilation and therapeutic support. It is also widely used in cutting cycles for fat loss, lean muscle preservation, and enhanced metabolism. Athletes and bodybuilders use SPIROCLEN to improve thermogenesis, endurance, and overall performance.

Enquire Now Download Catalogue

SPIROCLEN by Nova Techsciences is presented as an oral tablet containing Clenbuterol Hydrochloride 40 mcg. Clenbuterol Hydrochloride is a beta-adrenergic agonist identified by CAS Number 21898-19-1. PubChem classifies it as the hydrochloride salt of clenbuterol and notes its pharmacological role as a beta-adrenergic agonist and bronchodilator.

Clenbuterol has been authorised for limited medical uses in certain countries, but its regulatory status differs considerably between markets. Therefore, any indication or therapeutic claim displayed for SPIROCLEN must match the current marketing authorisation in the country where the product is offered.

SPIROCLEN Product Overview

Product name: SPIROCLEN
Active compound: Clenbuterol Hydrochloride
Strength: 40 mcg per tablet
Dosage form: Oral tablet
CAS Number: 21898-19-1
Brand: Nova Techsciences

The product label should clearly identify the full composition, tablet quantity, excipients, batch number, manufacturing date, expiry date and approved storage conditions. Information displayed on the website must remain consistent with the finished packaging, Certificate of Analysis and current regulatory documentation.

Quality Control and Traceability

A dependable SPIROCLEN product profile should be supported by appropriate pharmaceutical testing. Relevant controls may include raw-material identification, active-ingredient assay, tablet content uniformity, dissolution testing, impurity analysis, microbiological assessment and packaging-integrity verification.

Each manufactured batch should carry a unique number connected to its production history and laboratory-release results. Statements relating to pharmaceutical quality, purity or manufacturing standards should only be published when supported by verifiable records.

For the United Kingdom, Netherlands and other European markets, Nova Techsciences should clearly disclose the product’s marketing-authorisation status, legal supply category, responsible manufacturer and adverse-event reporting procedure.

Important Safety Information

Clenbuterol may affect the cardiovascular and nervous systems. Reported adverse effects can include palpitations, tremor and restlessness, while people with heart conditions, abnormal heart rhythms, high blood pressure or an overactive thyroid may face additional risks.

SPIROCLEN should not be presented as a weight-loss, fat-burning, cutting or bodybuilding product. It should not be used by minors or without appropriate medical supervision. Clenbuterol and other beta-2 agonists are also prohibited under the 2026 World Anti-Doping Agency Prohibited List, subject to limited exceptions for specified inhaled medicines.

Related Nova Techsciences Products

STANOVA 10

STANOVA 10 contains Stanozolol 10 mg, identified by CAS Number 10418-03-8. Stanozolol is an anabolic-androgenic steroid with separate liver, cardiovascular and hormonal safety concerns. Its information should emphasise regulatory status, contraindications and professional oversight rather than physique or performance claims.

STANOVA 50

STANOVA 50 contains Stanozolol 50 mg and shares CAS Number 10418-03-8 with the lower-strength formulation. The different strength should be displayed prominently to reduce selection errors. Batch documentation, liver-related precautions and legal supply requirements should be stated independently.

SUPERNOVA

SUPERNOVA is presented as a tablet containing Methyldrostanolone 10 mg, identified by CAS Number 3381-88-2. It is an oral anabolic compound requiring separate quality records, clear liver and cardiovascular warnings, verified regulatory status and prominent advice against unsupervised non-medical use.

TAMONOVA

TAMONOVA contains Tamoxifen Citrate 20 mg, associated with CAS Number 54965-24-1. Tamoxifen is a selective oestrogen-receptor modulator with authorised clinical uses and important risks, including blood-clot and pregnancy-related considerations. It should not be promoted for unsupervised post-cycle hormone management.

TELINOVA

TELINOVA contains Telmisartan 20 mg, identified by CAS Number 144701-48-4. Telmisartan is an antihypertensive medicine and is chemically unrelated to Clenbuterol Hydrochloride. Its information should cover blood-pressure monitoring, pregnancy restrictions, interactions, kidney considerations and authorised prescribing requirements.

SPIROCLEN should ultimately be presented through accurate chemical identification, transparent batch documentation, balanced safety information and clearly stated regulatory status.

Important Information & FAQs

Precautions & Contraindications

Precautions

Use only under medical guidance.
Do not exceed recommended dosage.
Avoid alcohol and stimulant substances.
Consult your doctor if taking other medications or supplements.
Keep out of reach of children.
Discontinue and seek medical help if unusual cardiovascular or respiratory symptoms occur.

Contraindications

Do not use if allergic to Clenbuterol or tablet ingredients.
Not recommended for individuals with heart conditions, arrhythmia, hypertension, hyperthyroidism, or severe liver/kidney disorders.
Avoid during pregnancy or breastfeeding.
Do not combine with other stimulants or fat-burners without supervision.